The only currently licensed malaria vaccine, RTS,S, is based on circumsporozoite protein (CSP), the most abundant and immunodominant protein on the surface of malaria sporozoites (SPZ), and yields only limited protection[3, 4]. The gene discussed is DNAJC5; the disease is malaria.